» Authors » Peter Luppa

Peter Luppa

Explore the profile of Peter Luppa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 412
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Reim D, Strobl A, Buchner C, Schirren R, Mueller W, Luppa P, et al.
Medicine (Baltimore) . 2016 Jul; 95(29):e4322. PMID: 27442682
The influence of perioperative transfusion (PT) on outcome following surgery for gastric cancer (GC) remains controversial, with randomized trials lacking and observational series confounded by patient risk factors. This analysis...
12.
Steubl D, Roos M, Hettwer S, Angermann S, Wen M, Schmaderer C, et al.
Kidney Blood Press Res . 2016 Mar; 41(2):175-85. PMID: 26959245
Background/aims: This study compares the peritoneal elimination of the low-molecular-weight-protein (LMWP) C-terminal agrin fragment (tCAF, size 22 kDa), a promising biomarker for kidney function, in continuous cycling peritoneal dialysis (CCPD)...
13.
Steubl D, Roos M, Hettwer S, Satanovskij R, Tholen S, Wen M, et al.
Clin Chem Lab Med . 2016 Feb; 54(9):1487-95. PMID: 26876812
Background: Total C-terminal agrin fragment (tCAF) is a new biomarker that was previously correlated with kidney function. This article studies the validity of tCAF as a biomarker for kidney function...
14.
Steubl D, Hettwer S, Dahinden P, Luppa P, Rondak I, Regenbogen C, et al.
Int Urol Nephrol . 2014 Oct; 47(2):391-6. PMID: 25352149
Background: C-terminal agrin fragment (CAF, size 22 kDa) is a promising new biomarker for kidney function. This study evaluated the usefulness of CAF as a serum biomarker for residual renal...
15.
Steubl D, Hettwer S, Dahinden P, Wolf P, Luppa P, Wagner C, et al.
Transl Res . 2014 Jun; 164(5):392-9. PMID: 24907476
C-terminal agrin fragment (CAF, 22 kDa) has been shown to be a promising new rapid biomarker for kidney function. This study evaluated the influence of hemodialysis (HD) and hemodiafiltration (HDF)...
16.
Steubl D, Hettwer S, Vrijbloed W, Dahinden P, Wolf P, Luppa P, et al.
Am J Nephrol . 2013 Dec; 38(6):501-8. PMID: 24356308
Background: The C-terminal agrin fragment (CAF) is a cleavage product of agrin, the major proteoglycan of the glomerular basement membrane. This article studies if CAF could serve as a biomarker...
17.
Al-Chalabi A, Matevossian E, V Thaden A, Luppa P, Neiss A, Schuster T, et al.
BMC Gastroenterol . 2013 May; 13:83. PMID: 23668774
Background: Mortality of patients with acute liver failure (ALF) is still unacceptably high. Available liver support systems are still of limited success at improving survival. A new type of albumin...
18.
Kellermann K, Gordan L, Blobner M, Luppa P, Kochs E, Jungwirth B
Thorac Cardiovasc Surg . 2013 Jan; 61(1):52-65. PMID: 23307276
Background: After adjusting for cofactors, female gender remains an independent risk factor. The aim of our study was to investigate the role of gender on functional outcome 14 days after...
19.
Erdmann J, Salmhofer H, Knauss A, Mayr M, Wagenpfeil S, Sypchenko O, et al.
Regul Pept . 2012 Mar; 178(1-3):6-10. PMID: 22387701
Objective: Weight gain and obesity are of substantial importance for the development of insulin-resistance and type-2 diabetes mellitus. Fetuin-A, a liver-derived glycoprotein, may also play a role in these alterations....
20.
Bott-Flugel L, Bernshausen A, Schneider H, Luppa P, Zimmermann K, Albrecht-Kupper B, et al.
PLoS One . 2011 Apr; 6(3):e18048. PMID: 21464936
The release of the neurotransmitter norepinephrine (NE) is modulated by presynaptic adenosine receptors. In the present study we investigated the effect of a partial activation of this feedback mechanism. We...